Log on / register
Feedback | Support | My details
Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia.
Raponi M, Belly RT, Karp JE, Lancet JE, Atkins D, Wang Y
BMC Cancer 2004 Aug 25, 4:56
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Tipifarnib in the treatment of acute myeloid leukemia.
Thomas X, Elhamri M
Biologics 2007 Dec, 1:415-24
[PubMed Central] [PubMed] [Related articles]

2.
Combined proteomics and pathways analysis of collecting duct reveals a protein regulatory network activated in vasopressin escape.
Hoorn EJ, Hoffert JD, Knepper MA
J Am Soc Nephrol 2005 Oct, 16:2852-63
[PubMed Central] [PubMed] [Related articles]

3.
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia.
Karp JE, Lancet JE
Biologics 2008 Sep, 2:491-500
[PubMed Central] [PubMed] [Related articles]

4.
Motif-specific sampling of phosphoproteomes.
Ruse CI, McClatchy DB, Lu B, Cociorva D, Motoyama A, Park SK, Yates JR
J Proteome Res 2008 May, 7:2140-50
[PubMed Central] [PubMed] [Related articles]

5.
Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma.
Rolland D, Camara-Clayette V, Barbarat A, Salles G, Coiffier B, Ribrag V, Thieblemont C
Cancer Chemother Pharmacol 2008 Apr, 61:855-63
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 2 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.